OPTHEA LIMITED Research and Development Expense
OPTHEA LIMITED (CYVNY) reported Research and Development Expense of $126.83 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-09-15.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2025-09-15
| Period end | Research And Development Expense 6 month | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|---|
| 2025-06-30 | $126.83M 20-F · filed 2025-09-15 | ||
| 2024-06-30 | $176.33M 20-F · filed 2025-09-15 | $176.33M 20-F · filed 2024-08-30 | |
| 2023-06-30 | $128.83M 20-F · filed 2025-09-15 | $122.13M 20-F · filed 2023-09-28 | |
| 2022-06-30 | $81.45M 20-F/A · filed 2024-09-20 | $78.65M 20-F · filed 2022-09-29 | |
| 2021-12-31 | $31.82M 6-K · filed 2022-03-30 | ||
| 2021-06-30 | $25.89M 20-F · filed 2023-09-28 | ||
| 2020-12-31 | $13.78M 6-K · filed 2022-03-30 | ||
| 2020-06-30 | $12.06M 20-F · filed 2022-09-29 | ||
| 2019-06-30 | $22.42M 20-F · filed 2021-10-28 |